I n their report, Albers et al. 1 present data on the potential clinical utility of immunohistochemical expression of Ki-67 in clinical Stage I nonseminomatous testicular germ cell tumors (NSGCT) to predict a group of patients at low risk for occult metastatic disease. Using a cutoff value of Γ΅70% M
β¦ LIBER β¦
Current and future biologic markers for disease progression and relapse in testicular germ cell tumors: A review
β Scribed by Masterson, Timothy A.; Rice, Kevin R.; Beck, Stephen D.W.
- Book ID
- 123424397
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 300 KB
- Volume
- 32
- Category
- Article
- ISSN
- 1078-1439
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Prognostic risk factors in low stage tes
β
Axel Heidenreich; Isabell A. Sesterhenn; Judd W. Moul
π
Article
π
1997
π
John Wiley and Sons
π
English
β 67 KB
π 2 views
Flow-cytometric and quantitative histolo
β
Werner T. W. de Riese; Cornelia de Riese; Thomas M. Ulbright; Edwin B. Walker; J
π
Article
π
1994
π
John Wiley and Sons
π
French
β 601 KB
Our study was performed to clarify whether the combination of DNA flow-cytornetric and quantitative histopathological parameters improves the prediction of occult metastatic disease in clinical stage-I non-seminomatous testicular germ-cell tumors (NSGCT). We used archival paraffin primary-tumor tiss
Incidence and survival for testicular ge
β
Qi Xu; Mark S. Pearce; Louise Parker
π
Article
π
2007
π
Elsevier Science
π
English
β 362 KB